Skip to main content
. 2019 May 7;27(5):583–592. doi: 10.3727/096504018X15368325811545

Table 5.

Factors Influencing CR Achievement by Logistic Regression Model Analysis

Parameters Univariate Logistic Regression Multivariate Logistic Regression
p Value OR 95% CI p Value OR 95% CI
Lower Higher Lower Higher
DEB-TACE (vs. cTACE) <0.001 7.255 2.485 21.179 0.002 5.858 1.949 17.606
Age > 61 years 0.648 0.812 0.331 1.991
Male 0.474 1.615 0.434 6.010
Two or more cycles of treatment 0.649 0.760 0.233 2.476
History of HB 0.413 1.727 0.466 6.400
History of cirrhosis 0.349 1.591 0.603 4.199
Previous cTACE treatment 0.456 1.410 0.572 3.479
Previous surgery 0.200 1.900 0.712 5.069
Previous systemic chemotherapy 0.982 +∞ <0.001 +∞
Previous radiofrequency ablation 0.661 0.703 0.145 3.404
Multifocal disease 0.559 0.758 0.298 1.924
Tumor size ≥ 5 cm 0.205 0.552 0.220 1.383
Tumor location-Bilobar 0.686 0.810 0.291 2.253
Venous invasion 0.017 0.158 0.035 0.714 0.108 0.271 0.055 1.333
Higher BCLC stage 0.124 0.629 0.348 1.135
Child–Pugh B stage (vs. A stage) 0.959 <0.001 <0.001 +∞
Higher ECOG performance status 0.939 0.971 0.454 2.076
AFP > 38.55 μg/L 0.026 0.334 0.127 0.879 0.189 0.490 0.169 1.422
CEA > 2.8 μg/L 0.276 0.600 0.240 1.503
CA19-9 > 14.35 ku/L 0.411 0.680 0.271 1.704

Data are presented as p value, OR (odds ratio), and 95% CI (confidence interval). Factors affecting CR achievement were determined by univariate logistic regression analysis, while all factors with p ≤ 0.1 were further detected by multivariate logistic regression analysis. A value of p < 0.05 was considered significant. BCLC stage was scored as 1-Stage A, 2-Stage B, 3-Stage C. CR, complete response.